All members have the option of attending our various HTC-centric events which include:

Two in-person member meetings a year (in spring and fall)
Regular Webinars educating our members on HTC operations & organizational management, payer relations, regulations and legal updates, and advocacy

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Pfizer on Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq)

May 6, 2025 @ 2:00 pm - 3:00 pm

Date: Tuesday, May 6th, 2025
Time: 2:00pm – 3:00pm ET

WEBINAR TOPIC:

Complications and challenges associated with hemophilia and a rebalancing approach with HYMPAVZI™ (marstacimab-hncq)

Educate attendees on complications and challenges associated with hemophilia, the novel mechanism of action of HYMPAVZI, the BASIS Ph3 clinical trial results and dosage and administration of HYMPAVZI
Discuss hypothetical patients who may benefit from HYMPAVZI along with a Q&A session.

SPEAKER:

Dr. Robert Sidonio, Jr., MD, MSc

- - - Medical Director of Hemophilia, Medical Director of the Clinical Research Office Aflac Cancer & Blood Disorders Center Children’s Healthcare of Atlanta
    - Associate Professor of Pediatrics, Emory University School of Medicine